Cargando…

A case of rhabdomyolysis related to sorafenib treatment for advanced hepatocellular carcinoma

We report on a case of rhabdomyolysis related to sorafenib treatment for advanced hepatocellular carcinoma. A 70-year-old man was admitted to our hospital with fatigue, myalgia and an elevated creatine phosphokinase level. He was diagnosed as rhabdomyolysis related to sorafenib treatment for advance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsuji, Kunihiro, Takemura, Kenichi, Minami, Keisuke, Teramoto, Ryota, Nakashima, Keisuke, Yamada, Shinya, Doyama, Hisashi, Oiwake, Hisanori, Hasatani, Kenkou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677972/ https://www.ncbi.nlm.nih.gov/pubmed/23766825 http://dx.doi.org/10.1007/s12328-013-0381-2

Ejemplares similares

Does long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?
por: Takeda, Yasuhito, et al.
Publicado: (2015)

Clinical outcomes of the “resect and discard” strategy using magnifying narrow-band imaging for small (< 10 mm) colorectal polyps
por: Tsuji, Shigetsugu, et al.
Publicado: (2018)

Importance of colonoscopy in patients undergoing endoscopic resection for superficial esophageal squamous cell carcinoma
por: Tominaga, Kei, et al.
Publicado: (2016)

Does Laparoscopic and Endoscopic Cooperative Surgery for Gastric Submucosal Tumors Preserve Residual Gastric Motility? Results of a Retrospective Single-Center Study
por: Waseda, Yohei, et al.
Publicado: (2014)

Immunoglobulin A Vasculitis in a Patient on Hemodialysis and With a Metastatic Liver Lesion
por: Yamamoto, Naoki, et al.
Publicado: (2021)

S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis
por: Tsuji, Kunihiro, et al.
Publicado: (2017)

Resection depth and layer of underwater versus conventional endoscopic mucosal resection of intermediate-sized colorectal polyps: A pilot study
por: Nomura, Hiroki, et al.
Publicado: (2022)

Usefulness of third‐generation narrow band imaging and texture and color enhancement imaging in improving visibility of superficial early gastric cancer: A study using color difference
por: Kawasaki, Azusa, et al.
Publicado: (2022)

The “white globe appearance” (WGA): a novel marker for a correct diagnosis of early gastric cancer by magnifying endoscopy with narrow-band imaging (M-NBI)
por: Doyama, Hisashi, et al.
Publicado: (2015)

Abdominal Subcutaneous Hematoma
por: Yamamoto, Naoki, et al.
Publicado: (2021)

Multiple Small Intestine Ulcers with Desquamation of the Fingers
por: Kawasaki, Azusa, et al.
Publicado: (2017)

Endoscopic omental packing in combination with the clip-and-snare method using pre-looping technique for gastric perforation
por: Yoshida, Naohiro, et al.
Publicado: (2023)

Factors Associated with Post-Progression Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
por: Otsuka, Taiga, et al.
Publicado: (2015)

Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
por: Mousa, Ali Ben
Publicado: (2008)

Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: Sanoff, Hanna K., et al.
Publicado: (2016)

Optimal number of endoscopic biopsies for diagnosis of early gastric cancer
por: Nishitani, Masaki, et al.
Publicado: (2019)

White globe appearance is an endoscopic predictive factor for synchronous multiple gastric cancer
por: Masunaga, Teppei, et al.
Publicado: (2021)

Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
por: SHAO, WENBO, et al.
Publicado: (2014)

Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma
por: Huang, Song-Fong, et al.
Publicado: (2022)

Late-onset benefit in progressive advanced hepatocellular carcinoma with continued sorafenib therapy: a case report
por: Okuwaki, Yusuke, et al.
Publicado: (2012)

Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma
por: Lee, Sangheun, et al.
Publicado: (2013)

Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis
por: Liu, Qinqin, et al.
Publicado: (2021)

Rhabdomyolysis after High Intensity Resistance Training
por: Honda, Sakiko, et al.
Publicado: (2017)

Usefulness of the clip-and-snare method using the pre-looping technique for endoscopic submucosal dissection of gastric neoplasia: a randomized controlled trial
por: Hasatani, Kenkei, et al.
Publicado: (2022)

Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
por: El Dika, Imane, et al.
Publicado: (2020)

Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma
por: Zhao, Yang, et al.
Publicado: (2019)

Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
por: Cha, Jihye, et al.
Publicado: (2013)

Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
por: Hsu, Chih-Hung, et al.
Publicado: (2014)

Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma
por: Takada, Hitomi, et al.
Publicado: (2018)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2017)

Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma
por: Marta, Guilherme Nader, et al.
Publicado: (2021)

Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Qian, Xinye
Publicado: (2023)

Intravoxel incoherent motion MRI as a biomarker of sorafenib treatment for advanced hepatocellular carcinoma: a pilot study
por: Shirota, Natsuhiko, et al.
Publicado: (2016)

Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma
por: NISHIKAWA, HIROKI, et al.
Publicado: (2012)

Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib
por: Choi, Joon-Il, et al.
Publicado: (2014)

Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
por: Leung, Henry W. C., et al.
Publicado: (2016)

Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib
por: Liu, Daizhong, et al.
Publicado: (2015)

Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom
por: Palmer, D H, et al.
Publicado: (2013)

Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
por: Zhuang, Lei, et al.
Publicado: (2017)

Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma
por: Ha, Yeonjung, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ln1ckhh8ho3t8loj6frfid8kd4